Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   marfan syndrome
  

Disease ID 91
Disease marfan syndrome
Definition
An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome is associated with mutations in the gene encoding fibrillin, a major element of extracellular microfibrils of connective tissue.
Synonym
marfan syndrome [disease/finding]
marfan syndrome, type i
marfan's disease
marfan's syndrome
marfan's syndrome (disorder)
marfans syndrome
mfs
mfs1
syndrome, marfan
syndrome, marfan's
Orphanet
OMIM
DOID
UMLS
C0024796
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:63)
C0003486  |  aortic aneurysm  |  8
C0003493  |  aortic disease  |  6
C0023316  |  lens subluxation  |  6
C0036439  |  scoliosis  |  4
C0878544  |  cardiomyopathy  |  4
C0026267  |  mitral valve prolapse  |  3
C0042373  |  vascular disease  |  3
C0017601  |  glaucoma  |  3
C0003486  |  aortic aneurysms  |  2
C0026265  |  mitral valve disease  |  2
C0152021  |  congenital heart disease  |  2
C2697932  |  loeys-dietz syndrome  |  2
C0155746  |  subclavian artery aneurysm  |  2
C0007193  |  dilated cardiomyopathy  |  2
C0026266  |  mitral regurgitation  |  2
C0235270  |  keratopathy  |  1
C0398623  |  thrombophilia  |  1
C0013990  |  emphysema  |  1
C0178879  |  urinary obstruction  |  1
C0033847  |  pseudoxanthoma elasticum  |  1
C0014122  |  infectious endocarditis  |  1
C0037315  |  sleep apnea  |  1
C0014118  |  endocarditis  |  1
C0017612  |  pigmentary glaucoma  |  1
C0037944  |  spinal stenosis  |  1
C0040997  |  trigeminal neuralgia  |  1
C0015310  |  exotropia  |  1
C0018799  |  cardiac disease  |  1
C0155111  |  bullous keratopathy  |  1
C0017605  |  angle-closure glaucoma  |  1
C0524812  |  intracranial hypotension  |  1
C0035309  |  retinal disease  |  1
C0028754  |  obesity  |  1
C0007222  |  cardiovascular disease  |  1
C0019291  |  hiatus hernia  |  1
C0006267  |  bronchiectasis  |  1
C0007115  |  thyroid ca  |  1
C0162872  |  thoracic aortic aneurysm  |  1
C0733682  |  x-linked hypophosphatemia  |  1
C0003076  |  aniridia  |  1
C0036529  |  secondary cardiomyopathy  |  1
C0032326  |  pneumothorax  |  1
C0020538  |  hypertension  |  1
C0220704  |  velocardiofacial syndrome  |  1
C0018801  |  heart failure  |  1
C0025362  |  mental retardation  |  1
C0023787  |  lipodystrophy  |  1
C0264716  |  chronic heart failure  |  1
C0007177  |  pericardial tamponade  |  1
C0002871  |  anaemia  |  1
C0549473  |  thyroid carcinoma  |  1
C0018799  |  heart disease  |  1
C0002878  |  haemolytic anaemia  |  1
C0031099  |  periodontitis  |  1
C0149931  |  migraine  |  1
C0012736  |  dissecting aortic aneurysm  |  1
C0221032  |  congenital lipodystrophy  |  1
C0027092  |  myopia  |  1
C0162871  |  abdominal aortic aneurysms  |  1
C0238463  |  papillary thyroid carcinoma  |  1
C0162871  |  abdominal aortic aneurysm  |  1
C0079744  |  diffuse large b-cell lymphoma  |  1
C0086543  |  cataract  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:10)
SOD1  |  6647  |  CTD_human
SOD2  |  6648  |  CTD_human
MMP9  |  4318  |  CTD_human
NOS2  |  4843  |  CTD_human
FBN1  |  2200  |  CLINVAR;CTD_human;UNIPROT;ORPHANET;GHR
CAT  |  847  |  CTD_human
TGFBR2  |  7048  |  CLINVAR;CTD_human
MMP2  |  4313  |  CTD_human
LTBP2  |  4053  |  CLINVAR
LAMC1  |  3915  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:3)
2200  |  FBN1  |  infer
7046  |  TGFBR1  |  infer
7048  |  TGFBR2  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:65)
1634  |  DCN  |  DISEASES
28954  |  REM1  |  DISEASES
368  |  ABCC6  |  DISEASES
8086  |  AAAS  |  DISEASES
4313  |  MMP2  |  DISEASES
59  |  ACTA2  |  DISEASES
4633  |  MYL2  |  DISEASES
4256  |  MGP  |  DISEASES
7166  |  TPH1  |  DISEASES
2006  |  ELN  |  DISEASES
1264  |  CNN1  |  DISEASES
3110  |  MNX1  |  DISEASES
10343  |  PKDREJ  |  DISEASES
53  |  ACP2  |  DISEASES
4087  |  SMAD2  |  DISEASES
2201  |  FBN2  |  DISEASES
1950  |  EGF  |  DISEASES
3373  |  HYAL1  |  DISEASES
2588  |  GALNS  |  DISEASES
54507  |  ADAMTSL4  |  DISEASES
185  |  AGTR1  |  DISEASES
1030  |  CDKN2B  |  DISEASES
6876  |  TAGLN  |  DISEASES
23657  |  SLC7A11  |  DISEASES
201163  |  FLCN  |  DISEASES
7547  |  ZIC3  |  DISEASES
1636  |  ACE  |  DISEASES
1409  |  CRYAA  |  DISEASES
28999  |  KLF15  |  DISEASES
1278  |  COL1A2  |  DISEASES
2990  |  GUSB  |  DISEASES
1281  |  COL3A1  |  DISEASES
649  |  BMP1  |  DISEASES
7399  |  USH2A  |  DISEASES
6578  |  SLCO2A1  |  DISEASES
137814  |  NKX2-6  |  DISEASES
2200  |  FBN1  |  DISEASES
633  |  BGN  |  DISEASES
5034  |  P4HB  |  DISEASES
286753  |  TUSC5  |  DISEASES
4088  |  SMAD3  |  DISEASES
5962  |  RDX  |  DISEASES
53827  |  FXYD5  |  DISEASES
4771  |  NF2  |  DISEASES
6677  |  SPAM1  |  DISEASES
7068  |  THRB  |  DISEASES
6525  |  SMTN  |  DISEASES
7048  |  TGFBR2  |  DISEASES
8076  |  MFAP5  |  DISEASES
4638  |  MYLK  |  DISEASES
1745  |  DLX1  |  DISEASES
22909  |  FAN1  |  DISEASES
5654  |  HTRA1  |  DISEASES
26036  |  ZNF451  |  DISEASES
186  |  AGTR2  |  DISEASES
7046  |  TGFBR1  |  DISEASES
5214  |  PFKP  |  DISEASES
4629  |  MYH11  |  DISEASES
4052  |  LTBP1  |  DISEASES
11277  |  TREX1  |  DISEASES
648791  |  PPP1R3G  |  DISEASES
93649  |  MYOCD  |  DISEASES
54900  |  LAX1  |  DISEASES
23218  |  NBEAL2  |  DISEASES
4607  |  MYBPC3  |  DISEASES
Locus(Waiting for update.)
Disease ID 91
Disease marfan syndrome
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:59)
HP:0002808  |  Kyphosis
HP:0001083  |  Ectopia lentis
HP:0005294  |  Arterial dissection
HP:0005059  |  Arthralgia/arthritis
HP:0004326  |  Cachexia
HP:0002097  |  Emphysema
HP:0001635  |  Congestive heart failure
HP:0002435  |  Meningocele
HP:0100775  |  Dural ectasia
HP:0004382  |  Mitral valve calcification
HP:0003326  |  Myalgia
HP:0001763  |  Pes planus
HP:0004933  |  Ascending aortic dissection
HP:0000678  |  Dental crowding
HP:0000545  |  Myopia
HP:0000347  |  Micrognathia
HP:0010807  |  Open bite
HP:0002636  |  Aneurysm of an abdominal artery
HP:0007676  |  Hypoplasia of the iris
HP:0005111  |  Dilatation of the ascending aorta
HP:0000767  |  Pectus excavatum
HP:0001382  |  Joint hypermobility
HP:0000501  |  Glaucoma
HP:0000541  |  Retinal detachment
HP:0000278  |  Retrognathia
HP:0002105  |  Hemoptysis
HP:0001166  |  Arachnodactyly
HP:0012369  |  Malar anomaly
HP:0001252  |  Muscular hypotonia
HP:0002705  |  High, narrow palate
HP:0000505  |  Visual impairment
HP:0000939  |  Osteoporosis
HP:0012432  |  Chronic fatigue
HP:0007800  |  Increased axial globe length
HP:0001065  |  Striae distensae
HP:0000768  |  Pectus carinatum
HP:0000275  |  Narrow face
HP:0001519  |  Disproportionate tall stature
HP:0001132  |  Lens subluxation
HP:0000938  |  Osteopenia
HP:0003302  |  Spondylolisthesis
HP:0002108  |  Spontaneous pneumothorax
HP:0012019  |  Lens luxation
HP:0000023  |  Inguinal hernia
HP:0000268  |  Dolichocephaly
HP:0002650  |  Scoliosis
HP:0002996  |  Limited elbow movement
HP:0000494  |  Downslanted palpebral fissures
HP:0002360  |  Sleep disturbance
HP:0007018  |  Attention deficit hyperactivity disorder
HP:0001533  |  Slender build
HP:0007720  |  Flat cornea
HP:0000175  |  Cleft palate
HP:0003202  |  Skeletal muscle atrophy
HP:0012499  |  Descending aortic dissection
HP:0004927  |  Pulmonary artery dilatation
HP:0006687  |  Aortic tortuosity
HP:0001634  |  Mitral valve prolapse
HP:0003179  |  Protrusio acetabuli
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:77)
HP:0002617  |  Aneurysmal dilatation  |  36
HP:0002647  |  Aortic dissection  |  22
HP:0001083  |  Dislocated lenses  |  11
HP:0004942  |  Aortic aneurysm  |  8
HP:0001132  |  Lens subluxation  |  6
HP:0100775  |  Dural ectasia  |  4
HP:0002650  |  Scoliosis  |  4
HP:0001724  |  Aortic dilatation  |  4
HP:0001638  |  Cardiomyopathy  |  4
HP:0000924  |  Abnormality of the skeletal system  |  3
HP:0001634  |  Mitral valve prolapse  |  3
HP:0000501  |  Glaucoma  |  3
HP:0002315  |  Headaches  |  2
HP:0000767  |  Funnel chest  |  2
HP:0001647  |  Bicuspid aortic valve  |  2
HP:0100790  |  Hernia  |  2
HP:0003179  |  Protrusio acetabulae  |  2
HP:0001653  |  Mitral valve insufficiency  |  2
HP:0001297  |  Cerebral vascular events  |  2
HP:0001644  |  Congestive cardiomyopathy  |  2
HP:0012180  |  Arterial cystic medial necrosis  |  2
HP:0100719  |  Lens coloboma  |  1
HP:0000526  |  Absent iris  |  1
HP:0001635  |  Congestive heart failure  |  1
HP:0100724  |  Hypercoagulability  |  1
HP:0002097  |  Pulmonary emphysema  |  1
HP:0004308  |  Ventricular arrhythmia  |  1
HP:0004927  |  Pulmonary artery dilatation  |  1
HP:0001238  |  Slender fingers  |  1
HP:0012727  |  Thoracic aortic aneurysm  |  1
HP:0000020  |  Bladder incontinence  |  1
HP:0002622  |  Dissecting aortic aneurysm  |  1
HP:0002631  |  Ascending aortic aneurysm  |  1
HP:0002119  |  Ventricular dilatation  |  1
HP:0004610  |  Narrow lumbar spinal canal  |  1
HP:0001903  |  Anemia  |  1
HP:0002907  |  Microhematuria  |  1
HP:0001878  |  Haemolytic anaemia  |  1
HP:0012641  |  Decreased intracranial pressure  |  1
HP:0012531  |  Pain  |  1
HP:0006702  |  Spontaneous coronary artery dissection  |  1
HP:0000766  |  Pectus deformity  |  1
HP:0002895  |  Papillary thyroid carcinoma  |  1
HP:0002036  |  Hiatus hernia  |  1
HP:0004937  |  Pulmonary artery aneurysm  |  1
HP:0003416  |  Spinal canal stenosis  |  1
HP:0002890  |  Thyroid carcinoma  |  1
HP:0000518  |  Cataract  |  1
HP:0004953  |  Abdominal aortic aneurysm  |  1
HP:0009125  |  Lipodystrophy  |  1
HP:0000545  |  Near sightedness  |  1
HP:0003077  |  Hyperlipidemia  |  1
HP:0002140  |  Ischemic stroke  |  1
HP:0002076  |  Migraine headaches  |  1
HP:0002104  |  Absence of spontaneous respiration  |  1
HP:0100661  |  Trigeminal neuralgia  |  1
HP:0000704  |  Pyorrhea  |  1
HP:0010535  |  Sleep apnea  |  1
HP:0000577  |  Exotropia  |  1
HP:0003418  |  Back pain  |  1
HP:0003419  |  Low back pain  |  1
HP:0002751  |  Kyphoscoliosis  |  1
HP:0011645  |  Aneurysm of the aortic sinus  |  1
HP:0011003  |  High myopia  |  1
HP:0100584  |  Endocarditis  |  1
HP:0000589  |  Ocular coloboma  |  1
HP:0000822  |  Hypertension  |  1
HP:0002107  |  Collapsed lung  |  1
HP:0002615  |  Low blood pressure  |  1
HP:0001513  |  Obesity  |  1
HP:0012378  |  Fatigue  |  1
HP:0000275  |  Decreased width of face  |  1
HP:0011675  |  Arrhythmias  |  1
HP:0001249  |  Mental retardation  |  1
HP:0001649  |  Tachycardia  |  1
HP:0002110  |  Bronchiectasis  |  1
HP:0001166  |  Long, slender fingers  |  1
Disease ID 91
Disease marfan syndrome
Manually Symptom
UMLS  | Name(Total Manually Symptoms:97)
C2712322  |  tachycardia
C2678504  |  osteoporosis
C2598155  |  pain
C2364133  |  infection
C2364051  |  fatigue
C2242765  |  spondylolisthesis
C2096315  |  headache
C2072946  |  aortic aneurysm
C2046121  |  aortic dissection
C1963229  |  retinal detachment
C1963215  |  pneumothorax
C1962986  |  glaucoma
C1962971  |  myocarditis
C1962958  |  hematoma
C1961102  |  acute lymphoblastic leukemia
C1866956  |  aortic root dilation
C1555769  |  pulmonary disease
C1555754  |  cardiovascular disease
C1541923  |  infective endocarditis
C1402315  |  vascular lesions
C1393529  |  vascular complications
C1298820  |  aortic root aneurysm
C1261470  |  meningocele
C1260873  |  aortic valve disease
C0948187  |  tracheomalacia
C0948089  |  acute coronary syndrome
C0856747  |  ascending aortic aneurysm
C0796140  |  rutherfurd syndrome
C0751731  |  spontaneous intracranial hypotension
C0751001  |  basilar artery aneurysm
C0743323  |  acute dyspnea
C0742215  |  cervical spine subluxation
C0741949  |  cardiovascular pathology
C0700361  |  distress
C0700208  |  scoliosis
C0524812  |  intracranial hypotension
C0427008  |  stiffness
C0398623  |  hypercoagulability
C0376293  |  stigmata
C0345050  |  annuloaortic ectasia
C0345050  |  annulo-aortic ectasia
C0344954  |  ventricular septal aneurysm
C0268731  |  glomerular disease
C0265010  |  ruptured thoracic aortic aneurysm
C0264967  |  extracranial internal carotid artery aneurysm
C0263445  |  acne fulminans
C0243050  |  cardiovascular abnormalities
C0238669  |  aortic root dilatation
C0231667  |  wrist sign
C0162872  |  thoracic aortic aneurysms
C0162872  |  thoracic aortic aneurysm
C0162871  |  abdominal aortic aneurysm
C0155746  |  subclavian artery aneurysm
C0149931  |  migraine
C0149781  |  spontaneous pneumothorax
C0078981  |  arachnoid cyst
C0042373  |  vascular disease
C0041327  |  pulmonary tuberculosis
C0040961  |  tricuspid regurgitation
C0039496  |  temporomandibular joint dysfunction
C0039070  |  syncope
C0037763  |  spasm
C0035305  |  retinal detachments
C0034067  |  pulmonary emphysema
C0033847  |  pseudoxanthoma elasticum
C0032962  |  complication of pregnancy
C0027765  |  neurological disorders
C0027092  |  myopia
C0026267  |  mitral valve prolapse
C0026266  |  mitral regurgitation
C0026266  |  mitral insufficiency
C0023418  |  leukemia
C0023316  |  subluxation of lens
C0022679  |  cystic kidneys
C0022658  |  renal disease
C0020546  |  hypertensive crisis
C0020545  |  renovascular hypertension
C0020302  |  buphthalmos
C0019555  |  developmental dysplasia of the hip
C0019270  |  hernia
C0019077  |  hemopneumothorax
C0018799  |  heart disease
C0016842  |  pectus excavatum
C0012736  |  dissecting aortic aneurysm
C0011401  |  pulp calcifications
C0010051  |  coronary artery aneurysm
C0007820  |  cerebrovascular disorders
C0007222  |  cardiovascular disorders
C0003504  |  aortic regurgitation
C0003504  |  aortic insufficiency
C0003493  |  aortic diseases
C0003493  |  aortic disease
C0003486  |  aortic aneurysms
C0002949  |  dissecting aneurysm
C0002940  |  aneurysms
C0002940  |  aneurysm
C0001363  |  acute mesenteric ischemia
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:34)
C0002940  |  aneurysm  |  24
C0340643  |  aortic dissection  |  22
C0002940  |  aneurysms  |  12
C0003486  |  aortic aneurysm  |  8
C0003493  |  aortic disease  |  6
C1298820  |  aortic root aneurysm  |  6
C1866956  |  aortic root dilation  |  5
C0036439  |  scoliosis  |  4
C0017601  |  glaucoma  |  3
C0042373  |  vascular disease  |  3
C0026267  |  mitral valve prolapse  |  3
C1393529  |  vascular complications  |  3
C0016842  |  pectus excavatum  |  2
C0018681  |  headache  |  2
C0019270  |  hernia  |  2
C0427008  |  stiffness  |  2
C0155746  |  subclavian artery aneurysm  |  2
C0026266  |  mitral regurgitation  |  2
C0012736  |  dissecting aortic aneurysm  |  1
C0032326  |  pneumothorax  |  1
C0751731  |  spontaneous intracranial hypotension  |  1
C0018799  |  heart disease  |  1
C0027092  |  myopia  |  1
C0015672  |  fatigue  |  1
C0007222  |  cardiovascular disease  |  1
C0162871  |  abdominal aortic aneurysm  |  1
C0231667  |  wrist sign  |  1
C0030193  |  pain  |  1
C0524812  |  intracranial hypotension  |  1
C0033847  |  pseudoxanthoma elasticum  |  1
C0162872  |  thoracic aortic aneurysm  |  1
C0039231  |  tachycardia  |  1
C0856747  |  ascending aortic aneurysm  |  1
C0149931  |  migraine  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:271)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs111231312NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468070GA
rs111401431NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468097GA
rs111588631215420602200FBN1umls:C0024796UNIPROTIn a first stage, genomic DNA from five MFS or LDS patient samples with previously identified mutations and/or polymorphisms in FBN1 and TGFBR1 and 2 were analyzed and revealed all expected variants.0.7226952992011NANANANANA
rs111671429NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548596311GC,A
rs111687884NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548537704GC,A
rs111801777NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548489875TC
rs111856492NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548415695CT,A
rs111929350NA2200FBN1umls:C0024796CLINVARNA0.722695299NANANANANANA
rs111929350117001572200FBN1umls:C0024796UNIPROTGenotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.0.7226952992001NANANANANA
rs112202622NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548490079CT,G,A
rs112287730NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548489977CT
rs112289537NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548516299G-
rs112375043215420602200FBN1umls:C0024796UNIPROTIn a first stage, genomic DNA from five MFS or LDS patient samples with previously identified mutations and/or polymorphisms in FBN1 and TGFBR1 and 2 were analyzed and revealed all expected variants.0.7226952992011FBN11548472594GC,A
rs112645512NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548516225GA
rs112660651117001572200FBN1umls:C0024796UNIPROTGenotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.0.7226952992001FBN11548610808CG,A
rs112660651NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548610808CG,A
rs112728248162226572200FBN1umls:C0024796UNIPROTIdentification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies.0.7226952992005NANANANANA
rs112836174NA2200FBN1umls:C0024796UNIPROTNA0.722695299NANANANANANA
rs112989722NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548437347GC,A
rs113001196NA2200FBN1umls:C0024796CLINVARNA0.722695299NANANANANANA
rs113086760NA2200FBN1umls:C0024796CLINVARNA0.722695299NANANANANANA
rs113249837NA2200FBN1umls:C0024796CLINVARNA0.722695299NANANANANANA
rs113422242108743202200FBN1umls:C0024796BeFreeEnzymatic mutation detection (EMD) of novel mutations (R565X and R1523X) in the FBN1 gene of patients with Marfan syndrome using T4 endonuclease VII.0.7226952992000NANANANANA
rs113544411162226572200FBN1umls:C0024796UNIPROTIdentification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies.0.7226952992005NANANANANA
rs113812345NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548513591GA
rs113871094NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548465820GA
rs113905529NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548596328GC,A
rs13785445618522082200FBN1umls:C0024796UNIPROTMarfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.0.7226952991991FBN11548487365CT,G,A
rs137854457NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548428423CT,G
rs13785445713019462200FBN1umls:C0024796UNIPROTClustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains.0.7226952991992FBN11548428423CT,G
rs137854458NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548483910CG
rs13785445813019462200FBN1umls:C0024796UNIPROTClustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains.0.7226952991992FBN11548483910CG
rs137854459NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548463977AG
rs13785445913019462200FBN1umls:C0024796UNIPROTClustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains.0.7226952991992FBN11548463977AG
rs137854460NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548432943CG
rs13785446013019462200FBN1umls:C0024796UNIPROTClustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains.0.7226952991992FBN11548432943CG
rs137854461NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548437026TC
rs137854461162205572200FBN1umls:C0024796UNIPROTIdentification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome.0.7226952992005FBN11548437026TC
rs137854462NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548510115TA
rs13785446284064972200FBN1umls:C0024796UNIPROTFour novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome.0.7226952991993FBN11548510115TA
rs13785446384064972200FBN1umls:C0024796UNIPROTFour novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome.0.7226952991993FBN11548497391TG
rs137854463NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548497391TG
rs13785446581368372200FBN1umls:C0024796UNIPROTInterestingly, the neonatal MFS mutations are clustered in one particular region of FBN1, possibly providing new insights into genotype-phenotype comparisons.0.7226952991994FBN11548488230AG
rs137854466NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411280GC,A
rs137854467NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548600217GA
rs137854467117001572200FBN1umls:C0024796UNIPROTGenotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.0.7226952992001FBN11548600217GA
rs13785446877625512200FBN1umls:C0024796UNIPROTAscending aortic disease, ranging from mild aortic root enlargement to aneurysm and/or dissection, has been identified in 10 individuals of a kindred, none of whom had classical Marfan syndrome (MFS).0.7226952991995FBN11548487396CT
rs137854468NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487396CT
rs13785446980719632200FBN1umls:C0024796UNIPROTA new missense mutation of fibrillin in a patient with Marfan syndrome.0.7226952991994FBN11548485418CT
rs137854469NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548485418CT
rs137854470146955402200FBN1umls:C0024796UNIPROTDetection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy.0.7226952992004FBN11548487425CT
rs137854470NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487425CT
rs137854471NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548483931CT
rs13785447181368372200FBN1umls:C0024796UNIPROTInterestingly, the neonatal MFS mutations are clustered in one particular region of FBN1, possibly providing new insights into genotype-phenotype comparisons.0.7226952991994FBN11548483931CT
rs137854472NA2200FBN1umls:C0024796UNIPROTNA0.722695299NAFBN11548488448TC
rs137854473NA2200FBN1umls:C0024796UNIPROTNA0.722695299NAFBN11548487384TA
rs13785447498378232200FBN1umls:C0024796UNIPROTA third family cosegregates mild mitral valve prolapse syndrome with a mutation in FBN1 that can be functionally distinguished from those associated with the classic MFS phenotype.0.7226952991998FBN11548483863AG
rs137854474NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548483863AG
rs13785447578700752200FBN1umls:C0024796UNIPROTMutations of the fibrillin gene (FBN1) are known to cause classical Marfan's syndrome, ectopia lentis and neonatal Marfan's syndrome.0.7226952991994FBN11548487155CT
rs137854475NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487155CT
rs137854476NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548513552GA
rs137854477104415972200FBN1umls:C0024796UNIPROTDemonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation.0.7226952991999FBN11548489979CT
rs13785447876112992200FBN1umls:C0024796UNIPROTFifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons.0.7226952991995FBN11548488233CT
rs137854479NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548497298TC
rs137854480NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548537629GA
rs137854480117001572200FBN1umls:C0024796UNIPROTGenotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.0.7226952992001FBN11548537629GA
rs137854482104250412200FBN1umls:C0024796UNIPROTIdentification of 9 novel FBN1 mutations in German patients with Marfan syndrome.0.7226952991999FBN11548487389CT
rs137854482NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487389CT
rs137854483NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548485424CT
rs137854855NA4053LTBP2umls:C0024796CLINVARNA0.120271442NALTBP21474551108GA
rs140537304NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548427699CT
rs140592NA2200FBN1umls:C0024796UNIPROTNA0.722695299NAFBN11548489947AG
rs140593NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548489896CT,G
rs140593117001572200FBN1umls:C0024796UNIPROTGenotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.0.7226952992001FBN11548489896CT,G
rs14059891507262200FBN1umls:C0024796BeFreeThe pathogenicity of the Pro1148Ala substitution in the FBN1 gene: causing or predisposing to Marfan syndrome and aortic aneurysm, or clinically innocent?0.7226952991997FBN11548487333GC
rs140599146955402200FBN1umls:C0024796UNIPROTDetection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy.0.7226952992004FBN11548487317CT
rs140603NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548503845GC,A
rs140603122039922200FBN1umls:C0024796UNIPROTTGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies.0.7226952992002FBN11548503845GC,A
rs140954477NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548490006CT
rs141133182NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548415735CT
rs141133182117001572200FBN1umls:C0024796UNIPROTGenotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.0.7226952992001FBN11548415735CT
rs145942328NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548613072CT
rs146726731NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548520779CT
rs147195031NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548420780GA
rs148076256NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548489907GC
rs148831709NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548428373CT
rs149062442NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548415588CT
rs191989961NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548474614CT
rs193921256NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495575GT,A
rs193922179NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548510124CT
rs193922181NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548510080-CGCATTACA
rs193922182NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548510049C-
rs193922183NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548510048AT
rs193922185NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548505037GA
rs193922186NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548503843GT
rs193922187NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548497373A-
rs193922188NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548496150CG
rs193922189NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495529AG
rs193922190NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495500AT
rs193922191NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495258TG
rs193922193NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495123CG
rs193922194NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548494250G-
rs193922197NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548488435GG-
rs193922198NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548488383C-
rs193922199NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487186CA
rs193922203NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548474300AC
rs193922204NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468542CT
rs193922205NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468527AT
rs193922206NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548596367TA
rs193922207NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468001AT
rs193922210NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548596337CT
rs193922212NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548452579GAGGTGAA-
rs193922214NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548448887TC
rs193922215NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548537791AG
rs193922216NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548448768CG
rs193922218NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN1;LOC1053708091548644714GA
rs193922219NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548446701CT,A
rs193922220NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548444565-GTATCCA
rs193922223NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548437072CA
rs193922224NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548537698AC
rs193922225NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548434653-CAAT
rs193922226NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548432901C-
rs193922227NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548430741-TTCTTGCA
rs193922228NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548430736AG
rs193922230NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548425840TG,C
rs193922233NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548425410GC
rs193922234NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548421591AC
rs193922235NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548421579G-
rs193922236NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548420700CT
rs193922239NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548415708CT
rs193922240NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548415689CG
rs193922241NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548412592C-
rs193922245NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN1;LOC1053708091548644687TC
rs193922246NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411189ATTTTA-
rs199474693NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548600196AC
rs200309328NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548412715GA,C
rs201273753NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548472617GC
rs25403122039922200FBN1umls:C0024796UNIPROTTGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies.0.7226952992002FBN11548613073GA
rs25403NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548613073GA
rs25404NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548613009CT
rs267606796NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411338CT
rs267606797NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548437362AC
rs267606798NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548465825CT
rs363804162205572200FBN1umls:C0024796UNIPROTIdentification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome.0.7226952992005FBN11548441771CT
rs363807NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548445430GA
rs363815118260222200FBN1umls:C0024796UNIPROTThese results indicate that CSGE is highly sensitive for the detection of mutations in FBN1, and that molecular diagnostics is a useful means of confirming clinical diagnoses of MFS and related disorders.0.7226952992002FBN11548437370AG
rs363853NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548596292AG
rs363853162226572200FBN1umls:C0024796UNIPROTIdentification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies.0.7226952992005FBN11548596292AG
rs397514558NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548490013GA
rs397515753NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548520755GA
rs397515754NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548516318TA
rs397515755NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548520711GT
rs397515756NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548516364TC
rs397515757NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548515382CT
rs397515758NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548513575CT-
rs397515759NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548510157CT
rs397515762NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548508581CA
rs397515765NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548497317AG
rs397515766NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548496178AG
rs397515767NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548613018CT
rs397515768NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548496112TA
rs397515769NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548496106AT-
rs397515770NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495561CG
rs397515771NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495560GC
rs397515773NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495520AC
rs397515774NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495519CG
rs397515775NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495513CT
rs397515776NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548495512AC
rs397515778NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548610805CCG
rs397515779NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548494240-A
rs397515781NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548492482C-
rs397515782NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548610775CA
rs397515784NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548489921GC
rs397515785NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN1;LOC1053708091548644730TAAATCCCAGG-
rs397515786NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548488412CT
rs397515788NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548488176C-
rs397515789NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548488112CT
rs397515790NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487383TC
rs397515791NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487362CA
rs397515792NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487311CA
rs397515793NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487075CT,G
rs397515794NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548600213CT
rs397515796NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548481771TG
rs397515797NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548481733AG
rs397515798NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548474599CG
rs397515799NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548474567AT
rs397515801NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548474305TC
rs397515802NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548472665AG
rs397515803NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548472628CACTGGCCA-
rs397515804NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548472628CT
rs397515805NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548470726CT,G
rs397515807NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548470729AC
rs397515808NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548470687CT,G
rs397515810NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468489CT
rs397515811NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468463AG
rs397515812108743202200FBN1umls:C0024796BeFreeEnzymatic mutation detection (EMD) of novel mutations (R565X and R1523X) in the FBN1 gene of patients with Marfan syndrome using T4 endonuclease VII.0.7226952992000FBN11548468427GA
rs397515812NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548468427GA
rs397515814NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548465573CT
rs397515816NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548465568CT
rs397515817NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548464009CT
rs397515818NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548596324CG
rs397515819NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548463241CG
rs397515820NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548460291GA
rs397515821NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548452670GA
rs397515823NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548452595CA
rs397515825NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548537786A-
rs397515826NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548446773GC
rs397515827NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548446747CT
rs397515828NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548445453CT
rs397515829NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548445424GA
rs397515830NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548441765CT
rs397515831NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548437792CA
rs397515833NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548437321CT
rs397515834NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548434694AAC
rs397515835NA2200FBN1umls:C0024796CLINVARNA0.722695299NANANANANANA
rs397515836NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548432975AC
rs397515837NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548432949AG
rs397515840NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548430701GA
rs397515845NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548427677CT
rs397515846NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548427603AG-
rs397515847NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548427603AG
rs397515848NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548427591GA
rs397515851NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548425368CA
rs397515852NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548422024AT-
rs397515853NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548421677TG
rs397515854NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548421651CT
rs397515859NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548415632CT
rs397515861NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411339CT
rs397515863NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411228TC
rs397515864NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411123GC
rs397515865NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411006TG
rs397515866NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411000AA-
rs397515867NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN1;LOC1053708081548526159-A
rs397516493NA7048TGFBR2umls:C0024796CLINVARNA0.260236045NATGFBR2330688458GTGTTGAGAGAT-
rs398122831NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548412639TT-
rs398122832NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548412620TTTGGGGTAGCCATTGATCT-
rs398122833NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548412568CA
rs398122934NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548472628CACTGGC-
rs587782944NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548513641CT
rs587782946NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548470688GA
rs587782947NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548446711CA
rs587782948NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411085CA
rs61746008NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548412619GA,C
rs6174600877382002200FBN1umls:C0024796UNIPROTA mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.0.7226952991995FBN11548412619GA,C
rs61746008193960332200FBN1umls:C0024796BeFreePrimary protrusio acetabuli may represent a hitherto unidentified metabolic defect, and a possible candidate for such genetic influence is the R2726W variant of the fibrillin 1 (FBN1) gene, which segregates with isolated skeletal features of individuals with Marfan syndrome.0.7226952992009FBN11548412619GA,C
rs672601352NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548516343GCACAGCTTGTT-
rs727503054NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548420752AG
rs727503056NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548467967GGAGTACCCCAGGCTTTACCCAGAGAACAGCAGCAGGAAGCTTT-
rs727503057NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548505106GA
rs727503058NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN1;LOC1053708091548644604AG
rs727504315NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548445405T-
rs727504347NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548463240T-
rs727504410NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548428457GA
rs727504411NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487118GT
rs727504454NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411131TCC-
rs727504651NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548411340AATCCT
rs727505006NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548487402GA
rs727505110NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548489991CG
rs727505269NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548537687G-
rs730880097NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN1;LOC1053708091548644769TC
rs730880098NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548610793CA
rs730880099NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548510125GA
rs730880100NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548488445CT
rs730880101NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548470640AG
rs730880103NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548460262AT
rs730880104NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548445432AC
rs730880105NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548503785AG
rs730880106NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548474254CT
rs730880107NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548432864AT
rs730880108NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548610753TA-
rs730880356NA2200FBN1umls:C0024796CLINVARNA0.722695299NAFBN11548515519-C
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:2)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0024796atenololD00126229122-68-7marfan syndromeMESH:D008382therapeutic19430350
C0024796doxycyclineD004318564-25-0marfan syndromeMESH:D008382therapeutic18178469
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)